Qualigen Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Qualigen Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Qualigen Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.27M, a 54.3% increase year-over-year.
  • Qualigen Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$6.71M, a 40% increase year-over-year.
  • Qualigen Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$11.3M, a 23.4% increase from 2022.
  • Qualigen Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$14.8M, a 34.9% increase from 2021.
  • Qualigen Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$22.7M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$11.3M +$3.46M +23.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-08
2022 -$14.8M +$7.9M +34.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-08
2021 -$22.7M Jan 1, 2021 Dec 31, 2021 10-K 2023-05-02
2019 -$10.8M +$7.05M +39.4% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-31
2018 -$17.9M -$9.99M -126% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-31
2017 -$7.9M +$10.5M +57.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$18.4M -$9.54M -107% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-19
2015 -$8.91M -$6.63M -290% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-27
2014 -$2.28M Jan 1, 2014 Dec 31, 2014 10-K 2016-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.